The pharmaceutical industry is increasingly turning to Bayesian methods in early phase trials in an attempt to improve efficiency and enhance decision making. One reason for this growing interest is the ability of Bayesian methods to leverage relevant external information, be this historical data or expert opinion. This 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods, and for eliciting expert prior information in situations where no or limited historical data are available.
Further updates and exact timings to the programme will be forthcoming.
Confirmed Speakers:
Nicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development
Nelson Kinnersley (Roche): Practical Considerations when Eliciting Expert Beliefs for Clinical Trial Design
Nelson will share experiences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation, training, conducting and documenting the outcomes will be described.
Tony O’Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere.
Kate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data
Beat Neuenschwander (Novartis): Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects
Registration on or before 23rd July
PSI Members: £100.00 (plus VAT)
Non-Members*: £140.00 (plus VAT)
Academics*: £40.00 (plus VAT)
Registration after 23rd July
PSI Members: £140.00 (plus VAT)
Non-Members*: £200.00 (plus VAT)
Academics*: £70.00 (plus VAT)
* Price includes 1 year PSI affiliate membership
Early registration is encouraged as places are limited.
The pharmaceutical industry is increasingly turning to Bayesian methods in early phase trials in an attempt to improve efficiency and enhance decision making. One reason for this growing interest is the ability of Bayesian methods to leverage relevant external information, be this historical data or expert opinion. This 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods, and for eliciting expert prior information in situations where no or limited historical data are available.
Further updates and exact timings to the programme will be forthcoming.
Confirmed Speakers:
Nicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development
Nelson Kinnersley (Roche): Practical Considerations when Eliciting Expert Beliefs for Clinical Trial Design
Nelson will share experiences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation, training, conducting and documenting the outcomes will be described.
Tony O’Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere.
Kate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data
Beat Neuenschwander (Novartis): Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects
Registration on or before 23rd July
PSI Members: £100.00 (plus VAT)
Non-Members*: £140.00 (plus VAT)
Academics*: £40.00 (plus VAT)
Registration after 23rd July
PSI Members: £140.00 (plus VAT)
Non-Members*: £200.00 (plus VAT)
Academics*: £70.00 (plus VAT)
* Price includes 1 year PSI affiliate membership
Early registration is encouraged as places are limited.
The pharmaceutical industry is increasingly turning to Bayesian methods in early phase trials in an attempt to improve efficiency and enhance decision making. One reason for this growing interest is the ability of Bayesian methods to leverage relevant external information, be this historical data or expert opinion. This 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods, and for eliciting expert prior information in situations where no or limited historical data are available.
Further updates and exact timings to the programme will be forthcoming.
Confirmed Speakers:
Nicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development
Nelson Kinnersley (Roche): Practical Considerations when Eliciting Expert Beliefs for Clinical Trial Design
Nelson will share experiences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation, training, conducting and documenting the outcomes will be described.
Tony O’Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere.
Kate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data
Beat Neuenschwander (Novartis): Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects
Registration on or before 23rd July
PSI Members: £100.00 (plus VAT)
Non-Members*: £140.00 (plus VAT)
Academics*: £40.00 (plus VAT)
Registration after 23rd July
PSI Members: £140.00 (plus VAT)
Non-Members*: £200.00 (plus VAT)
Academics*: £70.00 (plus VAT)
* Price includes 1 year PSI affiliate membership
Early registration is encouraged as places are limited.
The pharmaceutical industry is increasingly turning to Bayesian methods in early phase trials in an attempt to improve efficiency and enhance decision making. One reason for this growing interest is the ability of Bayesian methods to leverage relevant external information, be this historical data or expert opinion. This 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods, and for eliciting expert prior information in situations where no or limited historical data are available.
Further updates and exact timings to the programme will be forthcoming.
Confirmed Speakers:
Nicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development
Nelson Kinnersley (Roche): Practical Considerations when Eliciting Expert Beliefs for Clinical Trial Design
Nelson will share experiences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation, training, conducting and documenting the outcomes will be described.
Tony O’Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere.
Kate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data
Beat Neuenschwander (Novartis): Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects
Registration on or before 23rd July
PSI Members: £100.00 (plus VAT)
Non-Members*: £140.00 (plus VAT)
Academics*: £40.00 (plus VAT)
Registration after 23rd July
PSI Members: £140.00 (plus VAT)
Non-Members*: £200.00 (plus VAT)
Academics*: £70.00 (plus VAT)
* Price includes 1 year PSI affiliate membership
Early registration is encouraged as places are limited.
The pharmaceutical industry is increasingly turning to Bayesian methods in early phase trials in an attempt to improve efficiency and enhance decision making. One reason for this growing interest is the ability of Bayesian methods to leverage relevant external information, be this historical data or expert opinion. This 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods, and for eliciting expert prior information in situations where no or limited historical data are available.
Further updates and exact timings to the programme will be forthcoming.
Confirmed Speakers:
Nicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development
Nelson Kinnersley (Roche): Practical Considerations when Eliciting Expert Beliefs for Clinical Trial Design
Nelson will share experiences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation, training, conducting and documenting the outcomes will be described.
Tony O’Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere.
Kate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data
Beat Neuenschwander (Novartis): Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects
Registration on or before 23rd July
PSI Members: £100.00 (plus VAT)
Non-Members*: £140.00 (plus VAT)
Academics*: £40.00 (plus VAT)
Registration after 23rd July
PSI Members: £140.00 (plus VAT)
Non-Members*: £200.00 (plus VAT)
Academics*: £70.00 (plus VAT)
* Price includes 1 year PSI affiliate membership
Early registration is encouraged as places are limited.
The pharmaceutical industry is increasingly turning to Bayesian methods in early phase trials in an attempt to improve efficiency and enhance decision making. One reason for this growing interest is the ability of Bayesian methods to leverage relevant external information, be this historical data or expert opinion. This 1-day scientific meeting provides an opportunity to learn about some of the main techniques for incorporating historical data into study analyses using different discounting methods, and for eliciting expert prior information in situations where no or limited historical data are available.
Further updates and exact timings to the programme will be forthcoming.
Confirmed Speakers:
Nicky Best (GSK): Prior elicitation in practice: early experiences with eliciting expert beliefs to enhance decision making in drug development
Nelson Kinnersley (Roche): Practical Considerations when Eliciting Expert Beliefs for Clinical Trial Design
Nelson will share experiences gained from conducting elicitation sessions in the clinical trial domain. Aspects of preparation, training, conducting and documenting the outcomes will be described.
Tony O’Hagan (Sheffield University): Where do we need expert judgment in drug development? ... Everywhere.
Kate Ren (Sheffield University): Elicitation in clinical trial planning: time-to-event data
Beat Neuenschwander (Novartis): Using Co-Data in Early Phase Clinical Trials: Practical and Methodological Aspects
Registration on or before 23rd July
PSI Members: £100.00 (plus VAT)
Non-Members*: £140.00 (plus VAT)
Academics*: £40.00 (plus VAT)
Registration after 23rd July
PSI Members: £140.00 (plus VAT)
Non-Members*: £200.00 (plus VAT)
Academics*: £70.00 (plus VAT)
* Price includes 1 year PSI affiliate membership
Early registration is encouraged as places are limited.
Attendance at the course counts as 7.5 hours towards any CPD requirements
Many thanks to GSK
for hosting the September event.
If you would like to host a PSI one day meeting for a topic of particular
interest to you please contact: nickm@amgen.com
(Scientific Chair) PSI
Upcoming Events
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Date: The Second Wednesday of every Month
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
Date: Tuesday 10th December 2024
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Date: Thursday 12th December 2024
Chaired by Jenny Devenport, join us to hear Andy Grieve and Zhiwei Zhang discuss their recent work on group sequential designs.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
Date: October 2024 - July 2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
PSI Training Course: Mixed Models and Repeated Measures
Dates:
Monday 3rd February 2025: 08:30-13:00 BST
Tuesday 4th February 2025: 08:30 - 13:00 BST
Wednesday 5th February 2025: 08:30 - 13:00 BST
Thursday 6th February 2025: 08:30 - 13:00 BST
This course is presented through lectures and practical sessions using SAS code. It is suitable for statisticians working on clinical trials, who already have a good understanding of linear and generalised linear models.
We use cookies to collect and analyse information on site performance and usage, to provide social media features and to enhance and customise content and advertisements.
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them. When categories than have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser.
Additionally you can see a list of cookies assigned to each category and detailed information in the cookie declaration.
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Amazon Web Services offers a broad set of global cloud-based products including compute, storage, databases, analytics, networking, mobile, developer tools, management tools, IoT, security, and enterprise applications.
Preference cookies enables the web site to remember information to customize how the web site looks or behaves for each user. This may include storing selected currency, region, language or color theme.
Vimeo, Inc. is an American video hosting, sharing, services provider, and broadcaster. Vimeo focuses on the delivery of high-definition video across a range of devices.
vuid
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them. When categories than have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser.
Additionally you can see a list of cookies assigned to each category and detailed information in the cookie declaration.
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Necessary cookies
Name
Hostname
Vendor
Expiry
ARRAffinity
.psiweb.org
Session
This cookie is set by websites run on the Windows Azure cloud platform. It is used for load balancing to make sure the visitor page requests are routed to the same server in any browsing session.
ARRAffinitySameSite
.psiweb.org
Session
Used to distribute traffic to the website on several servers in order to optimize response times.
__cf_bm
.vimeo.com
Cloudflare, Inc.
1 hour
The __cf_bm cookie supports Cloudflare Bot Management by managing incoming traffic that matches criteria associated with bots. The cookie does not collect any personal data, and any information collected is subject to one-way encryption.
_cfuvid
.vimeo.com
Session
Used by Cloudflare WAF to distinguish individual users who share the same IP address and apply rate limits
__cf_bm
.glueup.com
Cloudflare, Inc.
1 hour
The __cf_bm cookie supports Cloudflare Bot Management by managing incoming traffic that matches criteria associated with bots. The cookie does not collect any personal data, and any information collected is subject to one-way encryption.
AWSALBTGCORS
psi.glueup.com
7 days
AWS Classic Load Balancer Cookie: Load Balancing Cookie: Used to map the session to the instance. Same value as AWSELB.
PHPSESSID
psi.glueup.com
Session
Cookie generated by applications based on the PHP language. This is a general purpose identifier used to maintain user session variables. It is normally a random generated number, how it is used can be specific to the site, but a good example is maintaining a logged-in status for a user between pages.
Used by CookieHub to store information about whether visitors have given or declined the use of cookie categories used on the site.
JSESSIONID
.nr-data.net
Session
General purpose platform session cookie, used by sites with JavaServer Pages (JSP). The cookie is usually used to maintain an anonymous user session by the server.
Preferences
Preference cookies enables the web site to remember information to customize how the web site looks or behaves for each user. This may include storing selected currency, region, language or color theme.
Preferences
Name
Hostname
Vendor
Expiry
vuid
.vimeo.com
400 days
These cookies are used by the Vimeo video player on websites.
AWSALBCORS
psi.glueup.com
7 days
Amazon Web Services cookie. This cookie enables us to allocate server traffic to make the user experience as smooth as possible. A so-called load balancer is used to determine which server currently has the best availability. The information generated cannot identify you as an individual.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.